Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Stańczak PS"'
Autor:
Grzybowski MM; Molecure SA, 02-089 Warsaw, Poland., Stańczak PS; Molecure SA, 02-089 Warsaw, Poland., Pomper P; Molecure SA, 02-089 Warsaw, Poland., Błaszczyk R; Molecure SA, 02-089 Warsaw, Poland., Borek B; Molecure SA, 02-089 Warsaw, Poland., Gzik A; Molecure SA, 02-089 Warsaw, Poland., Nowicka J; Molecure SA, 02-089 Warsaw, Poland., Jędrzejczak K; Molecure SA, 02-089 Warsaw, Poland., Brzezińska J; Molecure SA, 02-089 Warsaw, Poland., Rejczak T; Molecure SA, 02-089 Warsaw, Poland., Güner-Chalimoniuk NC; Molecure SA, 02-089 Warsaw, Poland., Kikulska A; Molecure SA, 02-089 Warsaw, Poland., Mlącki M; Molecure SA, 02-089 Warsaw, Poland., Pęczkowicz-Szyszka J; Molecure SA, 02-089 Warsaw, Poland., Olczak J; Molecure SA, 02-089 Warsaw, Poland., Gołębiowski A; Molecure SA, 02-089 Warsaw, Poland., Dzwonek K; Molecure SA, 02-089 Warsaw, Poland., Dobrzański P; Molecure SA, 02-089 Warsaw, Poland., Zasłona Z; Molecure SA, 02-089 Warsaw, Poland.
Publikováno v:
Cancers [Cancers (Basel)] 2022 Aug 17; Vol. 14 (16). Date of Electronic Publication: 2022 Aug 17.
Autor:
Pilanc P; Laboratory of Molecular Neurobiology, Nencki Institute of Experimental Biology of the Polish Academy of Sciences, Warsaw, Poland., Wojnicki K; Laboratory of Molecular Neurobiology, Nencki Institute of Experimental Biology of the Polish Academy of Sciences, Warsaw, Poland., Roura AJ; Laboratory of Molecular Neurobiology, Nencki Institute of Experimental Biology of the Polish Academy of Sciences, Warsaw, Poland., Cyranowski S; Laboratory of Molecular Neurobiology, Nencki Institute of Experimental Biology of the Polish Academy of Sciences, Warsaw, Poland.; Postgraduate School of Molecular Medicine, Medical University of Warsaw, Warsaw, Poland., Ellert-Miklaszewska A; Laboratory of Molecular Neurobiology, Nencki Institute of Experimental Biology of the Polish Academy of Sciences, Warsaw, Poland., Ochocka N; Laboratory of Molecular Neurobiology, Nencki Institute of Experimental Biology of the Polish Academy of Sciences, Warsaw, Poland., Gielniewski B; Laboratory of Molecular Neurobiology, Nencki Institute of Experimental Biology of the Polish Academy of Sciences, Warsaw, Poland., Grzybowski MM; OncoArendi Therapeutics SA, Warsaw, Poland., Błaszczyk R; OncoArendi Therapeutics SA, Warsaw, Poland., Stańczak PS; OncoArendi Therapeutics SA, Warsaw, Poland., Dobrzański P; OncoArendi Therapeutics SA, Warsaw, Poland., Kaminska B; Laboratory of Molecular Neurobiology, Nencki Institute of Experimental Biology of the Polish Academy of Sciences, Warsaw, Poland.
Publikováno v:
Frontiers in oncology [Front Oncol] 2021 Aug 24; Vol. 11, pp. 703465. Date of Electronic Publication: 2021 Aug 24 (Print Publication: 2021).
Autor:
Yamani A; Celon Pharma S.A., Medicinal Chemistry Department, Mokra 41A, Kiełpin, 05-092, Łomianki, Poland. Electronic address: abdellah.yamani@celonpharma.com., Zdżalik-Bielecka D; Celon Pharma S.A., Preclinical Development Department, Mokra 41A, Kiełpin, 05-092, Łomianki, Poland., Lipner J; Celon Pharma S.A., Medicinal Chemistry Department, Mokra 41A, Kiełpin, 05-092, Łomianki, Poland., Stańczak A; Celon Pharma S.A., Preclinical Development Department, Mokra 41A, Kiełpin, 05-092, Łomianki, Poland; Celon Pharma S.A., Clinical Trials Department, Ogrodowa 2A, Kiełpin, 05-092, Łomianki, Poland., Piórkowska N; Celon Pharma S.A., Medicinal Chemistry Department, Mokra 41A, Kiełpin, 05-092, Łomianki, Poland., Stańczak PS; Celon Pharma S.A., Preclinical Development Department, Mokra 41A, Kiełpin, 05-092, Łomianki, Poland., Olejkowska P; Celon Pharma S.A., Medicinal Chemistry Department, Mokra 41A, Kiełpin, 05-092, Łomianki, Poland., Hucz-Kalitowska J; Celon Pharma S.A., Preclinical Development Department, Mokra 41A, Kiełpin, 05-092, Łomianki, Poland., Magdycz M; Celon Pharma S.A., Medicinal Chemistry Department, Mokra 41A, Kiełpin, 05-092, Łomianki, Poland., Dzwonek K; Celon Pharma S.A., Preclinical Development Department, Mokra 41A, Kiełpin, 05-092, Łomianki, Poland., Dubiel K; Celon Pharma S.A., Medicinal Chemistry Department, Mokra 41A, Kiełpin, 05-092, Łomianki, Poland., Lamparska-Przybysz M; Celon Pharma S.A., Preclinical Development Department, Mokra 41A, Kiełpin, 05-092, Łomianki, Poland., Popiel D; Celon Pharma S.A., Preclinical Development Department, Mokra 41A, Kiełpin, 05-092, Łomianki, Poland., Pieczykolan J; Celon Pharma S.A., Preclinical Development Department, Mokra 41A, Kiełpin, 05-092, Łomianki, Poland., Wieczorek M; Celon Pharma S.A., Preclinical Development Department, Mokra 41A, Kiełpin, 05-092, Łomianki, Poland; Celon Pharma S.A., Clinical Trials Department, Ogrodowa 2A, Kiełpin, 05-092, Łomianki, Poland.
Publikováno v:
European journal of medicinal chemistry [Eur J Med Chem] 2021 Jan 15; Vol. 210, pp. 112990. Date of Electronic Publication: 2020 Nov 07.